reason report weekli
 equal-weight medic devic under-perform
broad market rel basi week declin
versu increas result year date
 medic devic hospit suppli index under-
perform modest
versu year-to-d gain
look ahead cy earn season begin week
medic devic coverag rate report
market open e/v rate report market close
wednesday april host non-deal roadshow ndr
o/v rate april may annual duke day take
place friday may contact stephen repres
inform also schedul attend upcom
american societi cataract refract surgeon ascr annual
meet american associ orthodontist
aesthet meet month may
announc result studi publish ophthalmolog glaucoma
compani istent specif use istent newli
diagnos primari open-angl glaucoma poag eye result
reduct mean iop mmhg five year
furthermor istent patient achiev treatment success
iop without add-on medic
secondari surgeri compar travoprost group
tuesday april fda order compani manufactur
surgic mesh transvagin repair anterior compart prolaps
stop sell product immedi one manufactur
fda believ demonstr reason assur
safeti effect rate importantli total surgic
mesh estim account total revenu
repres materi driver corpor growth fda action
clearli setback pertain uphold vagin support
xenform soft tissu repair matrix pelvic organ
prolaps offer combin repres portion total surgic
wednesday april publish note follow
extens multi-week market schedul highlight takeaway
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
sentiment importantli investor continu possess affin favor rel growth profil associ
health care industri tie term absolut growth behind energi comm servic
 sub sector within construct sub sector boast highest forward growth prospect
across healthcar sector follow healthcar servic biotech pharma
furthermor base meet estim share like continu
face headwind nearer-term base on-going investor concern like absolv prior enter
convers investor appear pivot favor addit increasingli
seek perceiv high-qual defens opportun respect end
note rate yet back investor vogu increasingli revisit investor
thursday april rate announc compani senior vice presid chief offic steven
voskuil resign effect may becom senior vice presid chief offic
hershey compani rate execut search process commenc identifi voskuil replac
opinion voskuil play integr role success transit former rate
spin attract medic devic pure play prospect acceler growth on-going margin expans
moreov move come time pois acceler organ growth deploy avail credit
also thursday publish industri note follow comprehens sell-off coverag univers
wednesday highlight etf exposur downsid risk revers trough multipl scenario rel
valuat base revis dodd framework event recessionari fear mount credit
subsequ tighten preemptiv look convert debt exposur
o/v rate announc health canada grant compani secret rf system medic devic licens recal
secret rf cutr radio frequenc rf microneedl system design stimul remodel collagen
notabl outsid coverag accord estim tax polici center million american
pay feder incom tax period result one incom threshold
payer qualifi refund tax credit greater amount tax owe
amazon rate alexa devic hippa compliant allow devic manag patient health
inform one exampl health-rel capabl alexa provid on-going monitor patient
discharg hospit importantli patient well caregiv ask alexa question patient case
doctor abl check-in remot use devic see patient progress recoveri process
tuesday april johnson johnson rate report first quarter specialti surgic sale growth
oper basi specif market dynam play larg expect intern sale
increas oper basi allergan rate textur implant market
 israel brazil domest sale declin million declin slightli
forecast assum modest million annual increas quarter end
day remain opinion domest market remain challeng fh benefit
heighten focu outcom volum concentr board certifi surgeon market pick
throughout
wednesday april plc rate releas data chare cross symposium london
endovascular repair abdomin aortic aneurysm patient use compani endur ii/ii stent graft system
conjunct mdt heli-fx endoanchor implant valiant navion thorac stent graft system thorac
endovascular repair tevar importantli two year freedom aneurysm relat mortal
freedom addit endovascular procedur valiant navion data demonstr
safeti efficaci incur peri-op mortal underw secondari procedur importantli
analysi occur includ subject intern multicent prospect studi
subject thorac aortic aneurysm taa penetr atherosclerot ulcer pau
also wednesday feder prosecutor charg dozen medic profession scheme distribut million
prescript drug script written across alabama kentucki tennesse west virginia specif
prosecutor accus doctor pharmacist nurs combin prescrib equival one dose
opioid everi man woman child across five state accord brian benczkowski head
depart justic crimin divis
rate report revenu billion versu street expect billion
adjust earn versu consensu expect per share importantli diabet
revenu increas report basi led compani cgm freestyl libr grew global revenu
report basi million
inc rate announc compani resum enrol transcend pivot clinic
trial srdx surveil drug-coat balloon dcb recal trial evalu compani dcb treatment
peripher arteri diseas pad upper leg
thursday april danah corpor rate report top bottom-lin beat revenu
billion pre-cal consensu billion adjust earn per share pre-cal consensu per
share importantli dhr dental segment report revenu million pre-cal consensu repres
declin compar oper period adjust fx headwind segment gener
revenu growth driven growth china north america furthermor dhr oper margin decreas
result price higher sale market invest fx
note dollar million except per share data ep elgx nxtm
fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
equiti percentag chang performersworst performersbest figur top fastest grow compani
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
non-cov compani mention figur page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
